Venus Concept

1800 Bering Dr, San Jose, California, United States304 employees

Also known as:

vero

venus concept inc.

vero.us

Venus Concept, Inc. is a global medical technology company, which engages in the business of developing, commercializing, and selling minimally invasive and non-invasive medical aesthetic and hair restoration technologies. It operates under the United States and International geographical segments. The company was founded on November 22, 2002 and is headquartered in Toronto, Canada.

Clinical Trials

1 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Not Applicable

100.0%

Trial Status Distribution

Active, not recruiting

2.9%

Completed

67.7%

Recruiting

8.8%

Terminated

14.7%

Unknown

2.9%

Withdrawn

2.9%

Clinical Trials

Trials sponsored by this organization (34)

Fractional Radiofrequency for Reduction of Surgical Scar Formation

Not Applicable

Unknown

interventional

Sep 202320 participants

Robotic Mechanical Coring for the Treatment of Moderate to Severe Facial Wrinkles

Not Applicable

Recruiting

interventional

Mar 202270 participants

Electrical Muscle Stimulation with 1064 Nm Diode Laser and RF/PEMF for Non-invasive Body Contouring and Fat Reduction.

Not Applicable

Active, not recruiting

interventional

Nov 202136 participants

Clinical Evaluation of the Safety and Performance of FRF for the Treatment and Reduction of Acne Scarring

Not Applicable

Completed

interventional

May 202120 participants

Mechanical Coring to Achieve Directional Skin Tightening

Not Applicable

Recruiting

interventional

Feb 202170 participants

Analysis of the Performance of 1060 nm Diode and Radio Frequency Prior to Abdominoplasty

Not Applicable

Completed

interventional

Jul 202012 participants

Subject Evaluation of a 1064nm Diode Laser/RF

Clinical Evaluation of a 1060 nm Diode Laser, PEMF and Vacuum Assisted MP RF for Non-invasive Fat Reduction

Not Applicable

Completed

interventional

Sep 201939 participants

Page 1 of 5

Approvals

No approval data available

News

Venus Concept Receives FDA 510(k) Clearance for Venus NOVA Multi-Application Aesthetic Platform

- Venus Concept has received FDA 510(k) clearance for Venus NOVA, a next-generation multi-application platform combining electrical muscle stimulation, radiofrequency, and electromagnetic fields for non-invasive body and skin treatments. - The platform integrates FlexMAX EMS technology capable of delivering up to 100,000 muscle contractions per session across 8 muscle groups, along with proprietary (MP)² technology combining Multi-Polar RF with Pulsed Electromagnetic Fields. - Venus NOVA is positioned to address the growing GLP-1 medication market, with the company expecting GLP-1 usage to reach over 32 million patients globally by 2030. - The device will be commercially available in the United States in December 2025, with global rollouts planned throughout 2026 and beyond.

Nov 10, 2025

Back to Organizations